Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: Highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis

Blood

Volumn 87, Issue 3, 1996, Pages 1045-1055

  D'Amore, Francesco ^a   Johansen, Preben ^b   Houmand, Annette ^b   Weisenburger, Dennis D ^b   Mortensen, Leif S ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLOPHOSPHAMIDE; DAUNORUBICIN DERIVATIVE; LACTATE DEHYDROGENASE; LATENT MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; PREDNISONE; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER STAGING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EPSTEIN BARR VIRUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; T CELL LYMPHOMA;

EID: 0030028835     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1045.bloodjournal8731045     Document Type: Article

References (61)

1. Liebowitz D, Kieff E: Epstein-Barr virus, in Roizman B, Whitley RJ, Lopez C (eds): The Human Herpesviruses. New York, NY, Raven, 1993, p 107
2. Epstein MA, Achong BG, Barr YM: Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702, 1964
3. Henle W, Henle G: Seroepidemiology of the virus, in Epstein MA, Achong BG (eds): Epstein-Barr Virus. New York, NY, Springer-Verlag, 1979, p 61
4. Henle G, Henle W: The virus as the infectious agent of infectious mononucleosis, in Epstein MA, Achong BG (eds): Epstein-Barr Virus. New York, NY, Springer-Verlag, 1979, p 257
5. zur Hausen H, Schulte-Holthausen H, Kleim H, Henle W, Henle G, Clifford P, Santesson L: EBV-DNA in biopsies of Burkitt's tumor and anaplastic carcinoma of the nasopharynx. Nature 228:1056, 1970
6. Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon KE, Rosenblum M, Holland JF: Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 312:1296, 1985
7. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131, 1994
8. Rabanus JP, Greenspan D, Petersen V, Leser U, Wolf H, Greenspan JS: Subcellular distribution and life-cycle of Epstein-Barr virus in keratinocytes of oral hairy leukoplakia. Am J Pathol 139:185, 1991
9. Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan JL, Synnerholm AC, Hanto D, Simmons R, Anvret M, Collins R, Klein G: Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA hybridization. Cancer Res 41:4237, 1981
10. Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH: Immunohistology of Epstein-Barr virus associated antigens in B-cell disorders from immunocompromised individuals. Transplantation 49:944, 1990
11. Ziegler J, Blackstead J, Volberding P, Abrams D, Levine A, Lukes R, Gill P, Burkes R, Meyer P, Metroka C, Mouradian J, Moore A, Riggs S, Butler J, Cabanillas F, Hersh E, Newell G, Laubenstein L, Knowles D, Odanjnyk C, Raphael B, Koziner B, Urmacher C, Clarkson B: Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphoadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565, 1984
12. Weiss L, Movahed LA, Warnke RA, Sklar J: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502, 1989
13. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J: T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733, 1988
14. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY: Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 77:799, 1991
15. Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G: High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 24.115, 1994
16. Korbjuhn P, Anagnostopoulos I, Hummel M, Tiemann M, Dallenbach F, Parwaresch MR, Stein H: Frequent latent Epstein-Barr virus infection of neoplastic T-cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood 82:217, 1993
17. Ott G, Ott M, Feller A, Seidl S, Muller-Hermelink HK: Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int J Cancer 51:562, 1992
18. Hamilton-Dutoit SJ, Pallesen G: A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Am J Pathol 140:1315, 1992
19. de Bruin PC, Jiwa NM, van der Valk P, van Heerde P, Gordijn R, Ossenkoppele GJ, Walboomers JMM, Meijer CJLM: Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: Relation between latent membrane protein-1 positivity and clinical course. Histopathology 23:509, 1993
20. Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, Gatter K, Dallenbach F, Parwaresch MR, Stein H: Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80:1804, 1992
21. Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ: Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79:1789, 1992
22. Ohshima K, Takeo H, Kikuchi M, Kozuru M, Uike N, Masuda Y, Yoneda S, Takeshita M, Shibata T, Akamatsu M: Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathology 25:569, 1994
23. Peiper SC: Angiocentric lymphoproliferative disorders of the respiratory system: Incrimination of Epstein-Barr virus in pathogenesis. Blood 82:687, 1993
24. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128, 1990
25. Ho FCS, Srivastava G, Loke SL, Fu KH, Leung BPY, Liang R, Choy D: Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol 8:271, 1990
26. Chan JKC, Yip TTC, Tsang WYW, Ng CS, Lau WH, Poon YF, Wong CCS, Ma VWS: Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 18:938, 1994
27. Weiss LM, Gaffey MJ, Chen YY, Frierson HF: Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol 16:156, 1992
28. Kanavaros P, Lescs MC, Briere J, Divine M, Galateau F, Joab I, Bosq J, Farcet JP, Reyes F, Gaulard P: Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81:2688, 1993
29. de Bruin PC, Jiwa M, Oudejans JJ, van der Valk P, van Heerde P, Sabourin JC, Csanaky G, Gaulard P, Noorduyn AL, Willemze R, Meijer CJLM: Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site. Blood 83:1612, 1994
30. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES: Nasal lymphomas in Peru. High incidence of T cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17:1194, 1993
31. d'Amore F, Brincker H, Grønbæk K, Thorling K, Pedersen M, Jensen MK, Andersen E, Pedersen NT, Mortensen LS: Non-Hodgkin's lymphoma of the gastrointestinal tract: A population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. J Clin Oncol 12:1673, 1994
32. Stansfeld AG, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrøm C, van Unnik JAM, Wright DH: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
33. Siegert W, Agthe A, Griesser H, Schwerdtfeger R, Brittinger G, Engelhard M, Kuse R, Tiemann M, Lennert K, Huhn D: Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IVMP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med 117.364, 1992
34. Siegert W, Nerl C, Engelhard M, Brittinger G, Tiemann M, Parwaresch R, Heinz R, Huhn D: Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: Prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepithelioid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group. Br J Haematol 87:529, 1994
35. Jaffe ES, Gonzalez CL, Madeiras LJ, Raffeld M: T-cell rich B-cell lymphomas. Am J Clin Pathol 103:65, 1991
36. Weiss LM, Chen YY: Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ hybridization using oligonucleotide probes. J Histochem Cytochem 39:1237, 1991
37. Glickman JN, Howe JG, Steitz JA: Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol 62:902, 1988
38. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N: Epstein-barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS associated leucoplakia. Proc Natl Acad Sci USA 87:8790, 1990
39. Knutson G, Spaulding D: β-actin as a positive control for detection of mRNA by in situ hybridization (ISH). Modern Pathol 8:166A, 1995 (abstr)
40. Cordell JL, Falini 13, Erber WN, Ghosh A, Abdulaziz Z, Mac Donald S, Pulford K, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
41. d'Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, Pedersen M, Krogh Jensen M, Johansen P, Andersen E, Bach B, Soerensen E: Clinicopathologic features and prognostic factors in extranodal non-Hodgkin's lymphomas. Eur J Cancer 27:1201, 1991
42. d'Amore F, Brincker H, Christensen BE, Thorling K, Pedersen M, Lanng Nielsen J, Sandberg E, Pedersen NT, Soerensen E: Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. Ann Oncol 3:379, 1992
43. Tarone RE, Ware J: On distribution-free tests for equality of survival distributions. Biometrika 64:156, 1977
44. Cox DR: Regression models and life tables. J R Stat Soc 34:187, 1972
45. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H: Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 74:810, 1989
46. Lopategui JR, Gaffey MJ, Chan JKC, Frierson HF, Sun LH, Bellafiore FJ, Chang KL, Weiss LM: Infrequent association of Epstein-Barr virus with CD 30-positive anaplastic large cell lymphomas of American and Asian patients. Am J Surg Pathol 19:42, 1995
47. Ross CW, Schlegelmilch JA, Grogan TM, Weiss LM, Schnitzer B, Hanson CA: Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction. Am J Pathol 141:457, 1992
48. Ohshima K, Kikuchi M, Eguchi F, Masuda Y, Sumiyoshi Y, Mohtai H, Takeshita M, Kimura N: Analysis of Epstein-Barr viral genomes in lymphoid malignancy using Southern blotting, polymerase chain reaction and in situ hybridization. Virchows Arch B Cell Pathol 59:383, 1990
49. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low- and high-grade types. J Pathol 175:263, 1995
50. Chen CL, Sadler RH, Walling DM, Su IH, Hsieh HC, Raab-Traub N: Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67:6303, 1993
51. Szckely L, Selivanova G, Magnusson KP, Klein G, Wiman K: EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 90:5455, 1993
52. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB: Activation of Epstein-Barr virus latent genes protects human B-cells from death by apoptosis. Nature 349:612, 1991
53. Tsoukas CD, Lambris JD: Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18:1299, 1988
54. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD: Infection of human thymocytes by Epstein Barr virus. J Exp Med 173:971, 1991
55. Kaufman Paterson RL, Kelleher CA, Streib JE, Amankonah TD, Wu Xu J, Jones JF, Gelfand EW: Activation of human thymocytes after infection by EBV J Immunol 154:1440, 1995
56. Kaufman Paterson RL, Kelleher CA, Amankonah TD, Streib JE, Wu Xu J, Jones JF, Gelfand EW: Model of Epstein-Barr virus infection of human thymocytes: Expression of viral genome and impact on cellular receptor expression in T-lymphoblastic cell line, HPB-ALL. Blood 85:456, 1995
57. Hedrick JA, Lao Z, Lipps SG, Wang Y, Todd SC, Lambris JD, Tsoukas CD: Characterization of a 70 kDa, EBV gp350/220-binding protein on HSB-1 T cells. J Immunol 153:4418, 1994
58. Cheng AL, Su IJ, Chen YC, Lee TC, Wang CH: Expression of p-glycoprotein and glutathione-S-transferase in recurrent lymphomas: The possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors. J Clin Oncol 11:109, 1993
59. Hu LF, Chen F, Zhen QF, Zhang YW, Luo Y, Zheng X, Winberg G, Ernberg I, Klein G: Differences in the growth pattern and clinical course of EBV-LMP1 expressing and nonexpressing nasopharyngeal carcinomas. Eur J Cancer 31A:658, 1995
60. Suzushima H, Asou N, Fujimoto T, Nishimura S, Okubo T, Yamasaki H, Osato M, Matsuoka M, Tsukamoto A, Takai K, Kawano F, Takatsuki K: Lack of expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. Blood 85:480, 1995
61. Sandvej K, Peh SC, Andresen BS, Pallesen G: Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84.4053, 1994